Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Intralesional antigen immunotherapy for warts in the era of COVID-19
By
- AMS
posted
Aug 17, 2020 01:52 PM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Intralesional immunotherapy for the treatment of anogenital warts in pediatric population
- AMS
Added Aug 06, 2020
Blog Entry
Use of systemic therapies for psoriasis in the COVID-19 era
- AMS
Added Jan 28, 2021
Blog Entry
‘Cryo-immuno-therapy’ is superior to intralesional Candida antigen monotherapy in the treatment of multiple common warts
- AMS
Added Feb 03, 2020
Blog Entry
The dermatology and esthetic practices in the era of COVID-19
- AMS
Added Aug 05, 2020
Blog Entry
Phototherapy and vitamin D: the importance in COVID-19 era
- AMS
Added Jun 22, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic